The Economics of Cancer Care: Implications for Family Caregivers

Part of the Caregiving: Research • Practice • Policy book series (CARE)


Evidence is mounting on the escalating costs of cancer care associated with family members who provide care to their loved one with cancer (Grunfeld et al., Canadian Medical Association Journal 170(12):1811–1812, 2004; Moore, Cancer Nursing 22(5):389–396, 1999; Muurinen, Medical Care 24(11):1007–1017, 1986). With a few exceptions, past research on the cost of cancer has been restricted to studying treatment, screening, or prevention costs (Sherman et al., Cancer 91(4):841–851, 2001; Stommel et al., Cancer 71(5):1867–1874, 1993). The majority of research related to the costs of cancer care for family caregivers has been associated with direct medical costs, and data from insurance companies, hospitals, and Medicare files have yielded significant findings. However, these same data sources have not been useful for determining the indirect costs borne by patients and their families. As a result, there is a growing need to capture the comprehensiveness of nonmedical costs associated with cancer care (Moore, Cancer Nursing 22(5):389–396, 1999; Sherman et al., Cancer 91(4), 841–851, 2001; Stommel et al., Cancer 71(5), 1867–1874, 1993).


Indirect Cost Cancer Care Family Caregiver American Cancer Society Health Care Expenditure 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. American Association of Caregiver Education (AACE). (2005). Medicare prescription coverage. Family caregiver alliance, caregiver information and advice, hot topics. Retrieved from Accessed 25 March 2012.
  2. American Cancer Society (ACS). (2003). Medical insurance and financial assistance for the cancer patient. Retrieved from Accessed 25 March 2012.
  3. Arno, P., Levine, C., & Memmott, M. (1999). The economic value of informal caregiving. Health Affairs, 18(2), 182–187.PubMedCrossRefGoogle Scholar
  4. Baldwin, D. (1996). A model for describing low-income African American women’s participation in breast and cervical caner early detection and screening. Advances in Nursing Science, 19, 27–42.PubMedCrossRefGoogle Scholar
  5. Bradley, C. J., Given, B., Given, C., & Kozachik, S. (2001). Physical, economic and social issues confronting patients and families. In C. Yarbro, M. Frogge, & M. Goodman (Eds.), Cancer nursing: Principles and practice (5th ed., pp. 1550–1564). Boston: Jones & Bartlett.Google Scholar
  6. Brown, M. L., & Fintor, L. (1995). The economic burden of cancer. In P. Greenwald, B. S. Kramer, & D. L. Weed (Eds.), Cancer prevention and control (pp. 69–81). New York: Dekker.Google Scholar
  7. Brown, M. L., Lipscomb, J., & Snyder, C. (2001). The burden of illness of cancer: Economic cost and quality of life. Annual Review of Public Health, 22, 91–113.PubMedCrossRefGoogle Scholar
  8. Brown, M. L., Riley, G. F., Schussler, N., & Etzioni, R. (2002). Estimating health care costs related to cancer treatment from SEER-Medicare data. Medical Care, 40(8), 104–117 (Supplement IV).Google Scholar
  9. Bulsa, C., Ward, A., & Joske, D. (2004). Haematological cancer patients: Achieving a sense of empowerment by use of strategies to control illness. Journal of Clinical Nursing, 13, 251–258.CrossRefGoogle Scholar
  10. CancerCare. (2012). General caregiver resources. Retrieved from Accessed 26 March 2012.
  11. Cassileth, B. (1979). The cancer patient: Social and medical aspects of care. Philadelphia: Lea and Febiger.Google Scholar
  12. Chang, S., Long, S., Kutikova, L., Bowman, L., Finely, D., Crown, W., et al. (2004). Estimating the cost of cancer: Results on the basis of claims data analyses for cancer patients diagnosed with seven types of cancer during 1999–2000. Journal of Clinical Oncology, 22(17), 3524–3529.PubMedCrossRefGoogle Scholar
  13. Connolly, C., & Allen, M. (2005, 9 February). Medicare drug benefit may cost $ 1.2 trillion, Washington Post, p. 1.Google Scholar
  14. Du, W., Touchette, D., Vaitkevicius, V., Peters, W., & Shields, A. (2000). Cost analysis of pancreatic carcinoma treatment. American Cancer Society, 89(9), 1917–1924.Google Scholar
  15. Eisenberg, J. M. (1979). Economics of cancer and its treatment. In B. Cassileth (Ed.), The cancer patient: Social and medical aspects of care (pp. 45–57). Philadelphia: Leas and Febiger.Google Scholar
  16. Fireman, B., Quesenberry, C., Somkin, C., Jacobson, A., Baer, D., West, D., et al. (2000). Cost of care for cancer in a health maintenance organization. Health Care Finance Review, 18, 51–76.Google Scholar
  17. Fishman, P., VonKorff, M., Lozano, P., & Hect, J. (1997). Chronic costs in managed care. Health Affairs, 16(3), 239–247.PubMedCrossRefGoogle Scholar
  18. Fleck, A. (1993). Cancer economics. In S. Groenwald, M. Hansen, M. Goodman, & C. Yarbro (Eds.), Cancer nursing: Principles and practice (3rd ed., pp. 1485–1516). Boston: Jones & Bartlett.Google Scholar
  19. Freeman, H. (1989). Cancer and the economically disadvantaged. Cancer, 64(1 Suppl.), 324–334.PubMedCrossRefGoogle Scholar
  20. Germino, B. A., & O’Rourke, M. (1996). Cancer and the family. In R. McCorkle, M. Grant, M. Frank-Stromborg, & S. Baird (Eds.), Cancer nursing: A comprehensive textbook (2nd ed., pp. 81–92). Philadelphia: Saunders.Google Scholar
  21. Given, B. A., & Given, C. W. (1997). Family caregiver burden from cancer care. In R. McCorkle, M. Grant, M. Frank-Stromborg, & S. Baird (Eds.), Cancer nursing: A comprehensive textbook (2nd ed., pp. 93–109). Philadelphia: Saunders.Google Scholar
  22. Given, B. A., Given, C. W., & Stommel, M. (1994). Family and out-of-pocket costs for women with breast cancer. Cancer Practice, 2, 187–193.PubMedGoogle Scholar
  23. Given, B. A., Given, C. W., & Kozzchik, S. (2001). Family support in advanced cancer. CA: A Cancer Journal for Clinicians, 51(4), 213–231.Google Scholar
  24. Gould, J. (2002). Lower-income women with breast cancer: Interacting with cancer treatment and income security systems. Canadian Woman Studies, 24(1), 31–36.Google Scholar
  25. Grunfeld, E., Coyle, D., Whelan, T., Clinch, J., Renyo, L., Earle, C., et al. (2004). Family caregiver burden: Results of a longitudinal study of breast cancer patients and their principal caregivers. Canadian Medical Association Journal, 170(12), 1811–1812.CrossRefGoogle Scholar
  26. Guidry, J. J., Aday, L., Zhang, D., & Winn, R. J. (1998). Cost considerations as potential barriers to cancer treatment. Cancer Practice, 6(3), 182–187.PubMedCrossRefGoogle Scholar
  27. Harper, M. S. (2000). Health policy issues and cancer in the elderly in the 21st century. In C. P. Hunter, K. A. Johnson, & H. B. Muss (Eds.), Cancer in the elderly (pp. 573–584). New York: Dekker.Google Scholar
  28. Hayman, J., Langa, K., Kabeto, M., Katz, S., DeMonner, S., Chernew, M., et al. (2001). Estimating the cost of informal caregiving for elderly patients with cancer. Journal of Clinical Oncology, 19(13), 3219–3225.PubMedGoogle Scholar
  29. Lukemeyer, A., Myers, M., & Smeeding, T. (2000). Expensive children in poor families: Out-of-pocket expenditures for the care of disabled and chronically ill children in welfare families. Journal of Marriage and the Family, 62, 399–415.CrossRefGoogle Scholar
  30. Moore, K. (1999). Breast cancer patients’ out-of-pocket expenses. Cancer Nursing, 22(5), 389–396.PubMedCrossRefGoogle Scholar
  31. Mortenson, L. (1996). Understanding cancer. In R. McCorkle, M. Grant, M. Frank-Stromborg, & S. Baird (Eds.), Cancer nursing: A comprehensive textbook (2nd ed., pp. 1345–1355). Philadelphia: Saunders.Google Scholar
  32. Muurinen, J. (1986). The economics of informal care: Labor market effects in the national hospice study. Medical Care, 24(11), 1007–1017.PubMedCrossRefGoogle Scholar
  33. National Cancer Institute (NCI). (2003). Infrastructure needed for cancer research: NCI’s challenge: Quality of cancer care. Washington: National Cancer Institute. Retrieved from Accessed 26 March 2012.
  34. National Cancer Institute (NCI). (2009). Cancer trends progress report—2009 update: Costs of cancer care. Retrieved from Accessed 26 March 2012.
  35. Navaie-Waliser, M., Feldman, P., Gould, D., Levine, C., Kuerbis, A., & Donelan, K. (2002). When the caregiver needs care: The plight of vulnerable caregivers. American Journal of Public Health, 92(3), 409–413.PubMedCrossRefPubMedCentralGoogle Scholar
  36. O’Mara, A. (2005). Who’s taking care of the caregiver? Journal of Clinical Oncology, 23(28), 1–2.Google Scholar
  37. Payne, D., Hoffman, G., Theodoulou, M., Dosik, M., & Massie, M. (1999). Screening for anxiety and depression in women with breast cancer. Psychosomatics, 40, 64–69.PubMedCrossRefGoogle Scholar
  38. Pasacreta, J. V., Barg, F., Nuamah, I., & McCorkle, R. (2000). Participant characteristics before and 4 months after attendance at a family caregiver cancer education program. Cancer Nursing, 23(4), 295–303.PubMedCrossRefGoogle Scholar
  39. Phillips, J. M., Cohen, M. Z., & Moses, G. (1999). Breast cancer screening and African American women: Fear, fatalism and silence. Oncology Nursing Forum, 22, 1383–1391.Google Scholar
  40. Rabow, M., Hauser, J., & Adams, J. (2004). Supporting family caregivers at the end of life. Journal of the American Medical Association, 291(4), 483–492.PubMedCrossRefGoogle Scholar
  41. Reed, M. C., & Hargraves, J. L. (2003). Prescription drug access disparities among working-age Americans (Issues Brief No. 73). Washington: Center for Studying Health System Change. Retrieved from Accessed 26 March 2012.
  42. Rutledge, V., & Stair, J. (1997). Impact of changing health care economics on cancer nursing practice. In S. Groenwald, M. Frogge, M. Goodman, & C. Yarbro (Eds.), Cancer nursing: Principles and practice (4th ed., pp. 1589–1607). Boston: Jones and Bartlett.Google Scholar
  43. Schulmeister, L. K. (1999). Cultural issues in cancer care. In C. Miaskowski & P. Buchsel (Eds.), Oncology nursing: Assessment and clinical care (pp. 383–399). St. Louis: Mosby.Google Scholar
  44. Sherman, E., Pfister, D., Ruchlin, H., Rubin, D., Radzyner, M., Kelleher, G., et al. (2001). The collection of indirect and nonmedical direct costs (COIN) form. Cancer, 91(4), 841–851.PubMedCrossRefGoogle Scholar
  45. Stommel, M., Given, C., & Given, B. A. (1993). The cost of cancer home care to families. Cancer, 71(5), 1867–1874.PubMedCrossRefGoogle Scholar
  46. Tamblyn, R., Laprise, R., Hanley, J., Abrahamowicz, M., Scott, S., Mayo, N., et al. (2001). Adverse events associated with prescription drug cost-sharing among poor and elderly persons. Journal of the American Medical Association, 285(4), 421–429.PubMedCrossRefGoogle Scholar
  47. U.S. Food and Drug Administration (FDA). (2009). FDA center for drug evaluation and research: Access to unapproved drugs. Retrieved from Accessed 26 March 2012.
  48. Vanderwerker, L. C., Laff, R. E., Kadan-lottick, N. S., McColl, S., & Prigerson, H. (2005). Psychiatric disorders and mental health service use among caregivers of advanced cancer patients. Journal of Clinical Oncology, 23(28), 6899–6907.PubMedCrossRefPubMedCentralGoogle Scholar
  49. Wein, S. (2000). The family in terminal illness. In L. Baider, C. L. Cooper, & K. De-Nour (Eds.), Cancer and the family (pp. 427–441). New York: Wiley.Google Scholar
  50. Wittes, R. (2004, 15 June). Cancer weapons out of reach. The Washington Post, p. A23.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.Georgia State UniversityDowntown AtlantaUSA
  2. 2.University of North Carolina at CharlotteCharlotteUSA

Personalised recommendations